Modern diagnostics such as endoscopy have supplanted traditional methods of diagnosing UTUC.
These subtypes have clinically meaningful differences in outcome, according to investigators.
No reduction in risk with increasing duration of metformin use relative to sulfonylureas.
Seventeen percent of Americans think that there is nothing people can do to change their risk.
In a study, bladder tumors recurred in 14.5% of patients following a five-year tumor-free period.
Study demonstrates an association with micropapillary urothelial carcinoma.
Information gained through image cytometry could shed light on disease recurrence and progression.
Death from PCa is down 45% from peak rates, but more than 29,000 men are projected to die from PCa in 2014.
Group proposes standard definition of progression in nonmuscle invasive bladder cancer.
It is associated with a reduced risk of cancer recurrence and progression, new findings suggest.
It also increases the risk of death from bladder cancer, according to a new study.
New findings identify STAG2 as one of the most commonly mutated genes in bladder cancer, particularly in tumors that do not metastasize.
Elderly patients face greater perioperative risks and postoperative mortality, so careful selection of surgical candidates is imperative.
More than half of all venous thromboembolism events were diagnosed after patient discharge.
Study suggests benefit of adding of emetine dihydrochloride to treatment.
Increased risk in first year after diagnosis limited to those with fewest doc visits in previous two years.
Compared with whites, Hispanics had an 88% increased odds of major post-cystectomy complications.
A device containing a sensor can indicate in approximately 30 minutes whether cancer cells are present in the bladder.
Risk of post-operative problems is linked to urinary diversion type.
Women in the highest quartile of total fruit and vegetable consumption had a 65% decreased risk compared with those in the lowest quartile.
These factors plus pathologic findings enable stratification of patients according to their risk of dying from bladder cancer after radical cystectomy.
Intravesical chemotherapy right after transurethral resection of bladder tumor prolonged the recurrence-free interval by 38%.
Routine screening for bladder cancer may be warranted in this patient population.
Increased prophylaxis may benefit patients with non-O blood type.
Lower urinary tract symptoms alone should raise suspicion for the malignancy.
Compared with non-smokers, heavy smokers had a 38% increased risk of having muscle-invasive disease at presentation.
A large observational study showed that cannabis users had a 45% decreased risk of developing the malignancy.
Only 2% of patients receive it after transurethral resection of bladder tumors, despite guideline recommendations.
Study reveals no decrease in death risk associated with perioperative and early follow-up care.
Patients aged 75 and older had longer stays in the intensive care unit and higher complication rates.